Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 60 years of age or older
- People who live independently in the community (not in a care facility)
- People who speak and understand English fluently
- People who have adequate vision and hearing ability (as reported by themselves)
- People who feel they have some challenges with memory, thinking, or concentration
- People who independently manage at least one prescribed blood pressure medication
- People who own and regularly use a smartphone
- People who have no history of major depression or other mental health diagnoses (as reported by themselves)
- People who have not been diagnosed with dementia or a neurological condition such as stroke, traumatic brain injury, or Parkinson's disease (as reported by themselves)
- People whose scores on two specific memory and thinking tests fall within a certain range — one test called the TICS-M (score between 27–37) and another called the MoCA (score between 20–26) (confirm with trial site)
- People who are willing to take part in the study for at least 4 months
Who may not be able to join:
- People who have been diagnosed with dementia
- People who live in an assisted living facility or a skilled nursing facility
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kathleen Insel, PhD, University of Arizona
Phone: 520-626-6220
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in medication adherence measured by the Medication Event Monitoring System (MEMS® Cap); Change in self-reported medication adherence measured by the Medication Adherence Report Scale-5 (MARS-5© Professor Rob Horne)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.